GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (XCNQ:BRAX) » Definitions » ROE % Adjusted to Book Value

Braxia Scientific (XCNQ:BRAX) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific ROE % Adjusted to Book Value?

Braxia Scientific's ROE % for the quarter that ended in Dec. 2023 was -4,293.49%. Braxia Scientific's PB Ratio for the quarter that ended in Dec. 2023 was N/A. Braxia Scientific's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.


Braxia Scientific ROE % Adjusted to Book Value Historical Data

The historical data trend for Braxia Scientific's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Braxia Scientific ROE % Adjusted to Book Value Chart

Braxia Scientific Annual Data
Trend Mar21 Mar22 Mar23
ROE % Adjusted to Book Value
-56.52 -73.42 -59.64

Braxia Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -124.34 -153.94 -39.93 -21.75 -

Competitive Comparison of Braxia Scientific's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Braxia Scientific's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Braxia Scientific's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Braxia Scientific's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Braxia Scientific's ROE % Adjusted to Book Value falls into.



Braxia Scientific ROE % Adjusted to Book Value Calculation

Braxia Scientific's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-248.71% / 4.17
=-59.64%

Braxia Scientific's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-4,293.49% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Braxia Scientific ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Braxia Scientific's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Braxia Scientific (XCNQ:BRAX) Business Description

Traded in Other Exchanges
Address
700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6
Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific (XCNQ:BRAX) Headlines

No Headlines